We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNW icon
901
Pinnacle West Capital
PNW
$11.6B
$1.43M 0.01%
16,759
-3,000
-15% -$265K
TSG
902
DELISTED
The Stars Group Inc.
TSG
$1.42M 0.01%
61,100
-14,600
-19% -$318K
LNC icon
903
Lincoln National
LNC
$8.33B
$1.41M 0.01%
18,287
-213
-1% -$16.1K
LCII icon
904
LCI Industries
LCII
$2.16B
$1.39M 0.01%
10,655
GCP
905
DELISTED
GCP Applied Technologies Inc.
GCP
$1.38M 0.01%
+43,300
New +$1.33M
APA icon
906
APA Corp
APA
$15.9B
$1.38M 0.01%
32,681
+2,211
+7% +$93K
RJF icon
907
Raymond James Financial
RJF
$32.1B
$1.38M 0.01%
23,100
CAH icon
908
Cardinal Health
CAH
$54.5B
$1.38M 0.01%
22,436
+13,645
+155% +$844K
INFY icon
909
Infosys
INFY
$45.3B
$1.37M 0.01%
169,436
-29,390
-15% -$223K
TTPH
910
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.36M 0.01%
10,817
+720
+7% +$92.2K
XLE icon
911
State Street Energy Select Sector SPDR ETF
XLE
$42.4B
$1.36M 0.01%
37,640
+1,000
+3% +$34.4K
GD icon
912
General Dynamics
GD
$97.8B
$1.36M 0.01%
6,682
+3,000
+81% +$613K
EWS icon
913
iShares MSCI Singapore ETF
EWS
$1.29B
$1.35M 0.01%
51,963
PJT icon
914
PJT Partners
PJT
$4.06B
$1.33M 0.01%
29,125
EIRL icon
915
iShares MSCI Ireland ETF
EIRL
$79.7M
$1.32M 0.01%
27,600
MANT
916
DELISTED
Mantech International Corp
MANT
$1.31M 0.01%
26,200
-98,600
-79% -$4.79M
CNBKA
917
DELISTED
Century Bancorp Inc/Mass
CNBKA
$1.3M 0.01%
16,624
+3,524
+27% +$297K
LOPE icon
918
Grand Canyon Education
LOPE
$3.98B
$1.29M 0.01%
14,400
-1,700
-11% -$154K
ULTA icon
919
Ulta Beauty
ULTA
$22.9B
$1.27M 0.01%
5,683
-24,223
-81% -$5.13M
EQC
920
DELISTED
Equity Commonwealth
EQC
$1.27M 0.01%
41,651
+34,455
+479% +$1.04M
SJR
921
DELISTED
Shaw Communications Inc.
SJR
$1.25M ﹤0.01%
54,879
+23,900
+77% +$539K
MSF
922
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$1.25M ﹤0.01%
70,000
ENOR icon
923
iShares MSCI Norway ETF
ENOR
$180M
$1.25M ﹤0.01%
48,300
FIZZ icon
924
National Beverage
FIZZ
$3B
$1.24M ﹤0.01%
25,400
-10,200
-29% -$523K
LCUT icon
925
Lifetime Brands
LCUT
$190M
$1.23M ﹤0.01%
74,805
+15,867
+27% +$282K

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.